Evidence map›Paper›PMID 35360162›Full record

ArticleFrontiers in neuroscience2022

Azepine-Indole Alkaloids From

Benjamin Kirchweger, Luiz C Klein-Junior, Dagmar Pretsch, Ya Chen, Sylvian Cretton, André L Gasper, Yvan Vander Heyden, Philippe Christen, Johannes Kirchmair, Amélia T Henriques and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. A Comprehensive Description of the Anatomy and Histochemistry ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Benjamin KirchwegerDepartment of Pharmaceutical Sciences, Division of Pharmacognosy, University of Vienna, Vienna, Austria.
Luiz C Klein-JuniorSchool of Health Sciences, Universidade do Vale do Itajaí (UNIVALI), Itajaí, Brazil.
Dagmar PretschDepartment of Pharmaceutical Sciences, Division of Pharmacognosy, University of Vienna, Vienna, Austria.
Ya ChenDepartment of Pharmaceutical Sciences, Division of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.
Sylvian CrettonInstitute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.
André L GasperHerbarium Dr. Roberto Miguel Klein, Department of Natural Sciences, Universidade Regional de Blumenau (FURB), Blumenau, Brazil.
Yvan Vander HeydenDepartment of Analytical Chemistry, Applied Chemometrics and Molecular Modeling, Center for Pharmaceutical Research (CePhaR), Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Philippe ChristenInstitute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.
Johannes KirchmairDepartment of Pharmaceutical Sciences, Division of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.
Amélia T HenriquesLaboratory of Pharmacognosy and Quality Control of Phytomedicines, Faculty of Pharmacy, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
Judith M RollingerDepartment of Pharmaceutical Sciences, Division of Pharmacognosy, University of Vienna, Vienna, Austria.
University of Vienna · ATHES-SO University of Applied Sciences and Arts Western Switzerland · CHUniversidade do Vale do Itajaí · BRUniversidade Federal do Rio Grande do Sul · BRUniversidade Regional de Blumenau · BRVrije Universiteit Brussel · BE

Funding

Austrian Science Fund FWF P 34028
6 · The paper itself

Abstract

Nemorosine A (

Indexed as

5-HT2Aalkaloidsbioactive natural productsCaenorhabditis elegansmolecular target predictionneurodegenerationPsychotria nemorosa

Identifiers

PMID35360162
PMCPMC8963987
OpenAlexW4220909458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.